| Date | Form | Description | Docs | XBRL | Pages |
| 03/16/99 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
16 | |
| 09/14/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 06/15/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/17/98 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 09/12/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
17 | |
| 06/13/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
15 | |
| 03/14/97 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
26 | |
| 09/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
13 | |
| 06/13/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 03/14/96 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
12 |
Latest News & Events
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
Read More...Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...